Expression of DP2 (CRTh2), a prostaglandin D2 receptor, in human mast cells

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Moon, Tae Chul ^a   Campos Alberto, Eduardo ^a   Yoshimura, Tsuyoshi ^a   Bredo, Graeme ^a   Rieger, Aja M ^a   Puttagunta, Lakshmi ^b   Barreda, Daniel R ^a   Befus, A Dean ^a   Cameron, Lisa ^a,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^c WESTERN UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

15 METHYL PROSTAGLANDIN D2; ACETYLSALICYLIC ACID; CALCIUM ION; CYTOKINE; MESSENGER RNA; PERTUSSIS TOXIN; PROSTAGLANDIN D2 DERIVATIVE; PROSTAGLANDIN RECEPTOR; PROTEIN CRTH2; UNCLASSIFIED DRUG; 15R-METHYL PROSTAGLANDIN D2; CALCIUM; IMMUNOGLOBULIN RECEPTOR; PROSTAGLANDIN D2; PROSTAGLANDIN D2 RECEPTOR;

ARTICLE; BASOPHIL; CALCIUM MOBILIZATION; CELL GRANULE; CELL LEVEL; CELL SURFACE; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAST CELL; MAST CELL DEGRANULATION; MEDIATOR RELEASE; NOSE POLYP; PROTEIN EXPRESSION; PROTEIN FUNCTION; TH2 CELL; AGONISTS; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; CYTOLOGY; CYTOSOL; DEGRANULATION; DRUG EFFECTS; GENE EXPRESSION; GENETICS; ION TRANSPORT; K562 CELL LINE; METABOLISM; MONONUCLEAR CELL; PRIMARY CELL CULTURE;

ASPIRIN; CALCIUM; CELL DEGRANULATION; CELL LINE; CYTOSOL; GENE EXPRESSION; HUMANS; ION TRANSPORT; K562 CELLS; LEUKOCYTES, MONONUCLEAR; MAST CELLS; NASAL POLYPS; PERTUSSIS TOXIN; PRIMARY CELL CULTURE; PROSTAGLANDIN D2; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; RNA, MESSENGER;

EID: 84907561103     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108595     Document Type: Article

References (70)

1. Marshall JS (2004) Mast-cell responses to pathogens. Nat Rev Immunol 4: 787-799.
2. Galli SJ, Nakae S, Tsai M (2005) Mast cells in the development of adaptive immune responses. Nat Immunol 6: 135-142.
3. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, et al. (2005) Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23: 749-786.
4. Moon TC, St Laurent CD, Morris KE, Marcet C, Yoshimura T, et al. (2010) Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal Immunol 3: 111-128.
5. Lewis RA, Soter NA, Diamond PT, Austen KF, Oates JA, et al. (1982) Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 129: 1627-1631.
6. Boyce JA (2005) Eicosanoid mediators of mast cells: receptors, regulation of synthesis, and pathobiologic implications. Chem Immunol Allergy 87: 59-79.
7. Peters-Golden M, Canetti C, Mancuso P, Coffey MJ (2005) Leukotrienes: underappreciated mediators of innate immune responses. J Immunol 174: 589 -594.
8. Joo M, Sadikot RT (2012) PGD synthase and PGD2 in immune response. Mediators Inflamm 2012: 503128.
9. Obata T, Nagakura T, Kanbe M, Masaki T, Maekawa K, et al. (1996) IgE-anti-IgE-induced prostaglandin D2 release from cultured human mast cells. Biochem Biophys Res Commun 225: 1015-1020.
10. Urade Y, Ujihara M, Horiguchi Y, Ikai K, Hayaishi O (1989) The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. J Immunol 143: 2982-2989.
11. Matsuoka T, Hirata M, Tanaka H, Takahashi Y, Murata T, et al. (2000) Prostaglandin D2 as a mediator of allergic asthma. Science 287: 2013-2017.
12. Pettipher R, Hansel TT, Armer R (2007) Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases. Nat Rev Drug Discov 6: 313-325.
13. Bochenek G, Nizankowska E, Gielicz A, Swierczynska M, Szczeklik A (2004) Plasma 9alpha, 11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. Thorax 59: 459-464.
14. Johnston SL, Freezer NJ, Ritter W, O'Toole S, Howarth PH (1995) Prostaglandin D2-induced bronchoconstriction is mediated only in part by the thromboxane prostanoid receptor. Eur Respir J 8: 411 -415.
15. Underwood DC, Muccitelli RM, Luttmann MA, Hay DW, Torphy TJ, et al. (1994) Differential antagonism of airway contractile responses to prostaglandin (PG)D2 and 9 alpha, 11 beta-PGF2 by atropine, SK&F 88046 and SQ 29,548 in the guinea pig. J Pharmacol Exp Ther 268: 304-310.
16. Beasley R, Hovel C, Mani R, Robinson C, Varley J, et al. (1988) Comparative vascular effects of histamine, prostaglandin (PG) D2 and its metabolite 9 alpha,11 beta-PGF2 in human skin. Clin Allergy 18: 619-627.
17. Fuller RW, Dixon CM, Dollery CT, Barnes PJ (1986) Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. Am Rev Respir Dis 133: 252-254.
18. Gosset P, Bureau F, Angeli V, Pichavant M, Faveeuw C, et al. (2003) Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. J Immunol 170: 4943-4952.
19. Xue L, Gyles SL, Wettey FR, Gazi L, Townsend E, et al. (2005) Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. J Immunol 175: 6531-6536.
20. Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, et al. (2001) Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 193: 255-261.
21. Gervais FG, Cruz RP, Chateauneuf A, Gale S, Sawyer N, et al. (2001) Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. J Allergy Clin Immunol 108: 982-988.
22. Mackay GA, Stewart AG (2011) R2D(2) for C(4) Eo: an 'alliance' of PGD(2) receptors is required for LTC(4) production by human eosinophils. Br J Pharmacol 162: 1671-1673.
23. Yoshimura-Uchiyama C, Iikura M, Yamaguchi M, Nagase H, Ishii A, et al. (2004) Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2. Clin Exp Allergy 34: 1283-1290.
24. Tajima T, Murata T, Aritake K, Urade Y, Hirai H, et al. (2008) Lipopolysaccharide induces macrophage migration via prostaglandin D(2) and prostaglandin E(2). J Pharmacol Exp Ther 326: 493-501.
25. Taketomi Y, Ueno N, Kojima T, Sato H, Murase R, et al. (2013) Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis. Nat Immunol 14: 554-563.
26. Nagata K, Hirai H (2003) The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes. Prostaglandins Leukot Essent Fatty Acids 69: 169-177.
27. Kostenis E, Ulven T (2006) Emerging roles of DP and CRTH2 in allergic inflammation. Trends Mol Med 12: 148-158.
28. Abe H, Takeshita T, Nagata K, Arita T, Endo Y, et al. (1999) Molecular cloning, chromosome mapping and characterization of the mouse CRTH2 gene, a putative member of the leukocyte chemoattractant receptor family. Gene 227: 71-77.
29. Mesquita-Santos FP, Bakker-Abreu I, Luna-Gomes T, Bozza PT, Diaz BL, et al. (2011) Co-operative signalling through DP(1) and DP(2) prostanoid receptors is required to enhance leukotriene C(4) synthesis induced by prostaglandin D(2) in eosinophils. Br J Pharmacol 162: 1674-1685.
30. Shirasaki H, Kikuchi M, Kanaizumi E, Himi T (2009) Accumulation of CRTH2-positive leukocytes in human allergic nasal mucosa. Ann Allergy Asthma Immunol 102: 110-115.
31. Boehme SA, Franz-Bacon K, Chen EP, Ly TW, Kawakami Y, et al. (2009) Murine bone marrow-derived mast cells express chemoattractant receptorhomologous molecule expressed on T-helper class 2 cells (CRTh2). Int Immunol.
32. Hirai H, Abe H, Tanaka K, Takatsu K, Sugamura K, et al. (2003) Gene structure and functional properties of mouse CRTH2, a prostaglandin D2 receptor. Biochem Biophys Res Commun 307: 797-802.
33. Butterfield JH, Weiler D, Dewald G, Gleich GJ (1988) Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 12: 345-355.
34. Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP, et al. (2003) Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk Res 27: 677-682.
35. Sekar Y, Moon TC, Slupsky CM, Befus AD (2010) Protein tyrosine nitration of aldolase in mast cells: A plausible pathway in nitric oxide-mediated regulation of mast cell function. J Immunol 185: 578-587.
36. Kirshenbaum AS, Goff JP, Semere T, Foster B, Scott LM, et al. (1999) Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD 13). Blood 94: 2333-2342.
37. Marcet CW, St Laurent CD, Moon TC, Singh N, Befus AD (2013) Limited replication of influenza A virus in human mast cells. Immunol Res 56: 32-43.
38. Moon TC, Lee E, Back SH, Murakami M, Kudo I, et al. (2003) Degranulation and cytokine expression in human cord blood-derived mast cells cultured in serum-free medium with recombinant human stem cell factor. Mol Cells 16: 154-160.
39. Yoshimura T, Moon TC, St Laurent CD, Puttagunta L, Chung K, et al. (2012) Expression of nitric oxide synthases in leukocytes in nasal polyps. Ann Allergy Asthma Immunol 108: 172-177.
40. Nagata K, Hirai H, Tanaka K, Ogawa K, Aso T, et al. (1999) CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s). FEBS Lett 459: 195-199.
41. Nagata K, Tanaka K, Ogawa K, Kemmotsu K, Imai T, et al. (1999) Selective expression of a novel surface molecule by human Th2 cells in vivo. J Immunol 162: 1278-1286.
42. Clarke DL, Belvisi MG, Smith SJ, Hardaker E, Yacoub MH, et al. (2005) Prostanoid receptor expression by human airway smooth muscle cells and regulation of the secretion of granulocyte colony-stimulating factor. Am J Physiol Lung Cell Mol Physiol 288: L238-250.
43. Ulanova M, Puttagunta L, Marcet-Palacios M, Duszyk M, Steinhoff U, et al. (2005) Syk tyrosine kinase participates in betal-integrin signaling and inflammatory responses in airway epitheEal cells. AmJ Physiol Lung Cell Mol Physiol 288: L497-507.
44. Campos Alberto E, Maclean E, Davidson C, Palikhe NS, Storie J, et al. (2012) The single nucleotide polymorphism CRTh2 rs533116 is associated with allergic asthma and increased expression of CRTh2. Allergy 67: 1357-1364.
45. Zuba-Surma EK, Kucia M, Abdel-Latif A, Lillard JW Jr, Ratajczak MZ (2007) The ImageStream System: a key step to a new era in imaging. Folia Histochem Cytobiol 45: 279-290.
46. Moon TC, Yoshimura T, Parsons T, Befus AD (2012) Microenvironmental regulation of inducible nitric oxide synthase expression and nitric oxide production in mouse bone marrow-derived mast cells. J Leukoc Biol 91: 581-590.
47. Monneret G, Cossette C, Gravel S, Rokach J, Powell WS (2003) 15R-methylprostaglandin D2 is a potent and selective CRTH2/DP2 receptor agonist in human eosinophils. J Pharmacol Exp Ther 304: 349-355.
48. Katada T, Ui M (1982) Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein. Proc Nad Acad Sci U S A 79: 3129-3133.
49. Katada T (2012) The inhibitory G protein G(i) identified as pertussis toxincatalyzed ADP-ribosylation. Biol Pharm Bull 35: 2103-2111.
50. Befus AD, Mowat C, Gilchrist M, Hu J, Solomon S, et al. (1999) Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action. J Immunol 163: 947-953.
51. Grigat J, Soruri A, Forssmann U, Riggert J, Zwirner J (2007) Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human alpha-defensin family. J Immunol 179: 3958-3965.
52. Roy SJ, Parent A, Gallant MA, de Brum-Fernandes AJ, Stankova J, et al. (2010) Characterization of C-terminal tail determinants involved in CRTH2 receptor trafficking: identification of a recycling motif. Eur J Pharmacol 630: 10-18.
53. Hamada K, Yamada Y, Kamada Y, Ueki S, Yamaguchi K, et al. (2004) Prostaglandin D2 and interleukin-5 reduce CRTH2 surface expression on human eosinophils. Allergology International 53: 179-184.
54. Columbo M, Horowitz EM, Botana LM, MacGlashan DW Jr, Bochner BS, et al. (1992) The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 149: 599-608.
55. El-Shazly AE, Moonen V, Mawet M, Begon D, Henket M, et al. (2011) IFN-gamma and TNF-alpha potentiate prostaglandin D2-induced human eosinophil chemotaxis through up-regulation of CRTH2 surface receptor. Int Immuno-pharmacol 11: 1864-1870.
56. Huber JP, Ramos HJ, Gill MA, Farrar JD (2010) Cutting edge: Type I IFN reverses human Th2 commitment and stability by suppressing GATA3. J Immunol 185: 813-817.
57. Bohm E, Sturm GJ, Weiglhofer I, Sandig H, Shichijo M, et al. (2004) 11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils. J Biol Ghem 279: 7663-7670.
58. Schuligoi R, Sedej M, Waldhoer M, Vukoja A, Sturm EM, et al. (2009) Prostaglandin H2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th2 cells, CRTH2. J Leukoc Biol 85: 136-145.
59. Chiba T, Ueki S, Ito W, Kato H, Kamada R, et al. (2011) The opposing role of two prostaglandin D2 receptors, DP and CRTH2, in human eosinophil migration. Ann Allergy Asthma Immunol 106: 511-517.
60. Hirai H, Tanaka K, Takano S, Ichimasa M, Nakamura M, et al. (2002) Cutting edge: agonistic effect of indomethacin on a prostaglandin D2 receptor, CRTH2. J Immunol 168: 981-985.
61. Ulven T, Kostenis E (2005) Minor structural modifications convert the dual TP/ CRTH2 antagonist ramatroban into a highly selective and potent CRTH2 antagonist. J Med Ghem 48: 897-900.
62. Crosignani S, Page P, Missotten M, Colovray V, Cleva C, et al. (2008) Discovery of a new class of potent, selective, and orally bioavailable CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases. J Med Ghem 51: 2227-2243.
63. Sugimoto H, Shichijo M, Okano M, Bacon KB (2005) CRTH2-specific binding characteristics of [3H]ramatroban and its effects on PGD2-, 15-deoxy-Deltal2, 14-PGJ2- and indomethacin-induced agonist responses. Eur J Pharmacol 524: 30-37.
64. Lu R, Kanai N, Bao Y, Schuster VL (1996) Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT). J Clin Invest 98: 1142-1149.
65. Chan BS, Satriano JA, Pucci M, Schuster VL (1998) Mechanism of prostaglandin E2 transport across the plasma membrane of HeLa cells and Xenopus oocytes expressing the prostaglandin transporter "PGT". J Biol Chem 273: 6689-6697.
66. Schuster VL (1998) Molecular mechanisms of prostaglandin transport. Annu Rev Physiol 60: 221-242.
67. Bao Y, Pucci ML, Chan BS, Lu R, Ito S, et al. (2002) Prostaglandin transporter PGT is expressed in cell types that synthesize and release prostanoids. Am J Physiol Renal Physiol 282: F1103-1110.
68. Mesquita-Santos FP, Vieira-de-Abreu A, Calheiros AS, Figueiredo IH, Castro-Faria-Neto HC, et al. (2006) Cutting edge: prostaglandin D2 enhances leukotriene C4 synthesis by eosinophils during allergic inflammation: synergistic in vivo role of endogenous eotaxin. J Immunol 176: 1326-1330.
69. Irannejad R, Xomshine JC, Xomshine JR, Chevalier M, Mahoney JP, et al. (2013) Conformational biosensors reveal GPCR signalling from endoso mes. Nature 495: 534-538.
70. Binda C, Genier S, Cartier A, Larrivee JF, Stankova J, et al. (2014) A G protein-coupled receptor and the intracellular synthase of its agonist functionally cooperate. J Cell Biol 204: 377-393.